Skip to main content
. 2019 Nov 15;35(3):714–722. doi: 10.3904/kjim.2018.404

Figure 3.

Figure 3.

Incidence of teicoplanin adverse drug reactions (ADRs) according to type of vancomycin hypersensitivity reaction. The incidences were 27.4% (skin reaction), 33.3% (drug fever), 27.0% (neutropenia), 16.7% (thrombocytopenia), 42.9% (eosinophilia), and 11.1% (others). Drug fever associated with vancomycin was significantly associated with occurrence of teicoplanin ADR. a p = 0.025 compared with patients who did not experienced specific reaction.